Press Releases Archives - EvolveImmune

Skip to content

Our Ambition
Our Science
Pipeline
Team
News
Careers
Contact Us

7th July 2022

EvolveImmune Therapeutics Appoints Jay Fine, Ph.D., as President of Research and Development

Bold Science.
LinkedIn Twitter

blazing new trails in the discovery and development of immunotherapies so that patients and caregivers who are fighting cancer can achieve better outcomes.

Better Outcomes.

Contact us

EvolveImmune Therapeutics, Inc.
Headquarters
23 Business Park Drive
Branford, CT 06405

info@evolveimmune.com
860-856-7104

Copyright © 2022

EvolveImmune. Privacy Policy.

Our Ambition
Our Science
Pipeline
Team
News
Careers
Contact Us

Top